8 studies found for:    cd13
Show Display Options
Rank Status Study
1 Unknown  Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis
Condition: Psoriasis
Intervention: Drug: IP10.C8
2 Completed Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)
Condition: Hematologic Malignancies
Interventions: Procedure: Unmanipulated PBSC after nonmyeloablative conditioning;   Procedure: CD8-depleted PBSC after nonmyeloablative conditioning
3 Completed BE Study of Naftifine HCL
Condition: Tinea Pedis
Interventions: Drug: Naftifine hydrochloride 2%;   Drug: Placebo;   Drug: Naftin® 2% (Naftifine hydrochloride 2%)
4 Recruiting The VERISMART Trial
Condition: Atrial Flutter
Intervention: Device: Ablation Catheter
5 Recruiting Iatrogenic Chronotropic Incompetence and Exercise Tolerance in Heart Failure
Condition: Chronic Heart Failure
Interventions: Drug: ivabradine;   Drug: Placebo;   Other: Exercise
6 Enrolling by invitation Stem Cell Transplantation for the Treatment of Knee Osteoarthritis
Condition: Knee Osteoarthritis
Intervention: Biological: Autologous Stem Cell Transplantation
7 Terminated Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
Conditions: Retinitis;   Behcet's Syndrome
Intervention: Biological: Autologous Stem Cell Transplantation
8 Terminated Tc-99m Renography and Cisplatin-induced Nephrotoxicity
Conditions: Cancer;   Drug Toxicity;   Kidney Failure
Intervention:

Indicates status has not been verified in more than two years